BioMedical Research Models Inc (BRM) Awarded a $3.0 Million NIH Grant to Advance a Mucosal HSV-2 Vaccine Towards Clinical Trials

June 10, 2014 Kejian Yang Ph.D., Vice President of Virology& Vaccine at BioMedical Research Models Inc has been awarded a three year grant from the National Institutes of Allergy and Infectious Disease (NIAID) totaling $2,999,168. The objectives of this grant are to advance BRM’s proprietary vaccine technology in order to develop a therapeutic and prophylactic strategy for genital herpes. The …